Although MYC amplification promotes aggressive breast cancer phenotype [7, 16, 21, 38], whether ATR and ATM expressions influence pathology and clinical outcomes in MYC overexpressed breast cancers is unknown. The gene discussed is ATM; the disease is breast cancer.